Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 25, 2010 04:40 ET | Source: BioPorto A/S

Q3 2010 - CORRECTION

Correction to Key figures on page 2, regarding cash flow. See attached file ...
November 25, 2010 04:40 ET | Source: BioPorto A/S

Q3 2010 - RETTELSE

Rettelser i hoved- og nøgletalsoversigt s. 2 vedr. pengestrøm Se vedhæftede fil ...
November 24, 2010 07:40 ET | Source: BioPorto A/S

Q3 2010

Summary of Q3 2010 The upscaling phase for the production of the NGAL Test has concluded, and the product design is finalized. The test was prelaunched for research use in November 2010 and is...
November 24, 2010 07:40 ET | Source: BioPorto A/S

Q3 2010

Resumé for 3. kvartal 2010 Opskaleringsfasen for produktion af The NGAL Test er afsluttet og produktdesignet er endeligt fastlagt. Testen er prælanceret til forskningsbrug i november 2010 og er p.t....
November 23, 2010 05:10 ET | Source: BioPorto A/S

Dako brings BioPorto's kidney injury test to the world market

From January 2011, Dako will be distributing The NGAL Test - BioPorto's new test for measuring acute kidney injury. "Dako is the perfect partner for us," says Thea Olesen, CEO of BioPorto....
November 23, 2010 05:10 ET | Source: BioPorto A/S

Dako bringer BioPortos nyreskadetest til verdensmarkedet

Fra januar 2011 skal Dako distribuere The NGAL Test - BioPortos nye test til måling af akut nyreskade. ”Dako er den helt rigtige partner for os” udtaler Thea Olesen, adm. direktør i BioPorto. ”Dako...
November 03, 2010 07:06 ET | Source: BioPorto A/S

BioPorto pre-launches pioneering kidney injury test

BioPorto is now pre-launching The NGAL Test for kidney injury in its new user-friendly format which can be used on most fully automated clinical chemistry analyzers. In preparation for the pre-launch,...
November 03, 2010 07:06 ET | Source: BioPorto A/S

BioPorto præ-lancerer banebrydende nyreskadetest

BioPorto præ-lancerer nu nyreskadetesten The NGAL Test i det nye brugervenlige format, der kan anvendes på de fleste fuldautomatiske diagnostiske apparater. Selskabet har op mod præ-lanceringen...
September 07, 2010 10:28 ET | Source: BioPorto A/S

BioPorto gennemfører udstedelse af konvertible obligationer

Bestyrelsen for BioPorto A/S besluttede den 26. august 2010 at udstede konvertible obligationer med et samlet lånebeløb på mindst DKK 7 millioner og højst DKK 20 millioner ved en rettet emission som...
September 07, 2010 10:28 ET | Source: BioPorto A/S

BioPorto completes the subscription of convertible bonds

On August 26, 2010, the Board of BioPorto A/S decided to take out convertible loans of the total nominal value of minimum DKK 7 million and maximum DKK 20 million through a private placement, as...